RGS
Click for more information
0.00% 12.0¢ regeneus ltd

In Interesting to read this thread and comments in the context...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Biotechasx
    76 Posts.
    lightbulb Created with Sketch. 5
    clock Created with Sketch.
    27/09/17
    07:59
    Post #: 27478740
    In
    Interesting to read this thread and comments in the context of yesterday's announcement about Sygenus results compared to morphine!
    RGS is certainly on a very upwards trend when it comes to R&D, trials and product pipeline.  

    All combined, this strengthens the assumption that the company's valuation is grossly underestimated with its current SP.
    RGS Price at posting: 15.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.